| Literature DB >> 30836804 |
Josephine A Menkin1, Heather E McCreath1, Sarah Y Song2, Carmen A Carrillo1, Carmen E Reyes1, Laura Trejo3, Sarah E Choi4, Phyllis Willis5, Elizabeth Jimenez6, Sina Ma7, Emiley Chang1, Honghu Liu1, Ivy Kwon8, John Kotick9, Catherine A Sarkisian1,10.
Abstract
Background Racial/ethnic minority older adults have worse stroke burden than non-Hispanic white and younger counterparts. Our academic-community partner team tested a culturally tailored 1-month (8-session) intervention to increase walking and stroke knowledge among Latino, Korean, Chinese, and black seniors. Methods and Results We conducted a randomized wait-list controlled trial of 233 adults aged 60 years and older, with a history of hypertension, recruited from senior centers. Outcomes were measured at baseline (T0), immediately after the 1-month intervention (T1), and 2 months later (T2). The primary outcome was pedometer-measured change in steps. Secondary outcomes included stroke knowledge (eg, intention to call 911 for stroke symptoms) and other self-reported and clinical measures of health. Mean age of participants was 74 years; 90% completed T2. Intervention participants had better daily walking change scores than control participants at T1 (489 versus -398 steps; mean difference in change=887; 97.5% CI, 137-1636), but not T2 after adjusting for multiple comparisons (233 versus -714; mean difference in change=947; 97.5% CI, -108 to 2002). The intervention increased the percent of stroke symptoms for which participants would call 911 (from 49% to 68%); the control group did not change (mean difference in change T0-T1=22%; 99.9% CI, 9-34%). This effect persisted at T2. The intervention did not affect measures of health (eg, blood pressure). Conclusions This community-partnered intervention did not succeed in increasing and sustaining meaningful improvements in walking levels among minority seniors, but it caused large, sustained improvements in stroke preparedness. Clinical Trial Registration URL : http://www.clinicaltrials.gov . Unique identifier: NCT 02181062.Entities:
Keywords: Community‐based participatory research; aging; minority health; walking
Mesh:
Year: 2019 PMID: 30836804 PMCID: PMC6475057 DOI: 10.1161/JAHA.118.011088
Source DB: PubMed Journal: J Am Heart Assoc ISSN: 2047-9980 Impact factor: 5.501
Figure 1CONSORT flow diagram. AA indicates African American; CA, Chinese American; KA, Korean American; LT, Latino; T0, baseline; T1, immediately postintervention; T2, 2 months postintervention.
Demographic and Baseline Health Characteristics
| Total (N=233) | Intervention (n=120) | Control (n=113) | |
|---|---|---|---|
| Demographics | |||
| Age, y | 73.9 (0.4) | 74.1 (0.6) | 73.6 (0.6) |
| Female, N (%) | 161 (69.1) | 82 (68.3) | 79 (69.9) |
| Black, N (%) | 55 (23.6) | 28 (23.3) | 27 (23.9) |
| Latino, N (%) | 63 (27.0) | 31 (25.8) | 32 (28.3) |
| Chinese American, N (%) | 55 (23.6) | 30 (25.0) | 25 (22.1) |
| Korean American, N (%) | 60 (25.8) | 31 (25.8) | 29 (25.7) |
| Did not complete high school, N (%) | 97 (41.6) | 43 (35.8) | 54 (47.8) |
| Baseline health status | |||
| Mean steps/day | 4934 (209) | 4548 (292) | 5343 (301) |
| Stroke preparedness | 0.51 (0.02) | 0.49 (0.03) | 0.54 (0.03) |
| Inactivity as stroke risk factor, N (%) | 49 (21.0) | 26 (21.7) | 23 (20.4) |
| Disease and exercise self‐efficacy | 7.6 (0.1) | 7.6 (0.2) | 7.6 (0.2) |
| Outcome expectations for exercise | 1.8 (0.3) | 1.8 (0.5) | 1.8 (0.5) |
| Systolic BP, mm Hg | 124.9 (1.2) | 122.9 (1.5) | 127.0 (2.0) |
| Diastolic BP, mm Hg | 66.3 (0.7) | 65.7 (1.0) | 67.0 (1.1) |
| BMI, kg/m2 | 28.4 (0.4) | 28.2 (0.6) | 28.6 (0.6) |
| Proportion no ADL limitations | 0.74 (0.03) | 0.67 (0.04) | 0.82 (0.04) |
| Katz comorbidity index score | 2.0 (0.1) | 2.1 (0.2) | 1.8 (0.2) |
| Non HDL cholesterol, mg/dL | 121.1 (3.0) | 118.1 (4.4) | 124.3 (4.0) |
| % HbA1c (whole‐blood equivalent) | 6.0 (0.1) | 6.0 (0.1) | 5.9 (0.1) |
| Log CRP (plasma equivalent) | 0.06 (0.04) | 0.02 (0.06) | 0.11 (0.06) |
| Physical‐health–related QOL | 42.1 (0.7) | 41.1 (0.9) | 43.3 (0.9) |
| Mental‐health–related QOL | 50.3 (0.7) | 49.8 (0.9) | 50.8 (0.9) |
| Depressive symptomology | 4.9 (0.4) | 5.3 (0.6) | 4.4 (0.5) |
| Visits to physician in past 3 mo | 2.3 (0.1) | 2.6 (0.2) | 2.0 (0.1) |
| Total nights in hospital in past 3 mo | 0.3 (0.1) | 0.5 (0.2) | 0.2 (0.1) |
Mean (SE), unless otherwise specified. ADL indicates activities of daily living; BMI, body mass index; BP, blood pressure; CRP, C‐reactive protein; HbA1c, glycated hemoglobin; HDL, high‐density lipoprotein; QOL, quality of life.
Change in Study Outcomes From Baseline (T0) to Immediately After Intervention Completed (T1)
| Outcome | Change From Baseline Unadjusted Mean [95% CI] | Intervention Regression Coefficient Predicting Change | ||
|---|---|---|---|---|
| Intervention | Control | b [95% CI] |
| |
| Primary | ||||
| Steps/day | 489 [−13 to 990] | −398 [−834 to 38] | 887 [233–1540] | 0.008 |
| Secondary, self‐reported | ||||
| Stroke preparedness | 0.19 [0.13–0.25] | −0.02 [−0.07 to 0.02] | 0.22 [0.15–0.29] | <0.001 |
| Inactivity as stroke risk factor | 0.2 [0.1–0.3] | 0.1 [0.03–0.20] | 0.4 [−0.2 to 0.9] | 0.161 |
| Self‐efficacy | 0.30 [0.02–0.58] | −0.1 [−0.4 to 0.2] | 0.37 [−0.02 to 0.77] | 0.063 |
| Exercise outcome expectations | −0.1 [−0.200 to <0.001] | 0.02 [−0.06 to 0.11] | −0.12 [−0.25 to 0.01] | 0.072 |
| Secondary, clinical | ||||
| Systolic BP | −1.2 [−4.5 to 2.0] | −2.8 [−6.2 to 0.6] | 1.5 [−3.2 to 6.2] | 0.52 |
| Diastolic BP | −0.7 [−2.6 to 1.2] | −2.1 [−3.9 to −0.4] | 1.4 [−1.2 to 4.1] | 0.27 |
| BMI | −0.02 [−0.16 to 0.13] | 0.05 [−0.07 to 0.16] | −0.06 [−0.25 to 0.12] | 0.50 |
| Exploratory | ||||
| Physical‐health–related QOL | −1.0 [−2.7 to 0.6] | −2.1 [−3.7 to −0.5] | 1.1 [−1.2 to 3.3] | 0.35 |
| Mental‐health–related QOL | −0.1 [−1.9 to 1.7] | 0.2 [−1.4 to 1.7] | −0.2 [−2.6 to 2.2] | 0.86 |
| Depressive symptomology | 0.3 [−0.6 to 1.2] | 0.3 [−0.6 to 1.1] | 0.02 [−1.2 to 1.2] | 0.98 |
| ADL category | 0.05 [−0.16 to 0.25] | 0.12 [−0.05 to 0.29] | −0.01 [−0.58 to 0.57] | 0.98 |
Intervention regression coefficient reflects mean difference between intervention and control conditions in level of change from T0 to T1. Models use regression with imputed values. ADL indicates activities of daily living; BMI, body mass index; BP, blood pressure; QOL, quality of life.
Ordinal logistic regression.
Change in Study Outcomes From Baseline (T0) to 2 Months After Intervention Completed (T2)
| Outcome | Change From Baseline Unadjusted Mean [95% CI] | Intervention Regression Coefficient Predicting Outcome | ||
|---|---|---|---|---|
| Intervention | Control | b [95% CI] |
| |
| Primary | ||||
| Steps/day | 233 [−508 to 973] | −714 [−1264 to −164] | 947 [27–1867] | 0.044 |
| Secondary, self‐report | ||||
| Stroke preparedness | 0.18 [0.12–0.24] | −0.03 [−0.07 to 0.02] | 0.20 [0.13–0.28] | <0.001 |
| Inactivity as stroke risk factor | 0.07 [−0.03 to 0.17] | 0.05 [−0.04 to 0.15] | 0.07 [−0.52 to 0.66] | 0.83 |
| Self‐efficacy | 0.23 [−0.08 to 0.55] | −0.36 [−0.67 to −0.04] | 0.59 [0.15–1.03] | 0.009 |
| Exercise outcome expectations | −0.11 [−0.20 to −0.02] | −0.01 [−0.11 to 0.08] | −0.10 [−0.23 to 0.03] | 0.137 |
| Secondary, clinical | ||||
| Systolic BP | −1.7 [−5.1 to 1.8] | −3.8 [−7.0 to −0.6] | 2.1 [−2.6 to 6.9] | 0.38 |
| Diastolic BP | −1.2 [−3.2 to 0.8] | −2.7 [−4.5 to −0.9] | 1.43 [−1.3 to 4.1] | 0.29 |
| BMI | −0.14 [−0.33 to 0.05] | −0.01 [−0.20 to 0.18] | −0.13 [−0.40 to 0.14] | 0.35 |
| Non‐HDL cholesterol | 1.7 [−7.2 to 10.7] | −10.0 [−19.5 to −0.4] | 11.7 [−1.6 to 25.0] | 0.083 |
| HbA1c | −0.10 [−0.28 to 0.07] | 0.02 [−0.11 to 0.15] | −0.12 [−0.34 to 0.09] | 0.26 |
| logCRP | −0.03 [−0.12 to 0.07] | −0.01 [−0.13 to 0.11] | −0.02 [−0.17 to 0.13] | 0.81 |
| Exploratory | ||||
| Physical‐health–related QOL | 0.6 [−1.0 to 2.1] | 0.3 [−1.4 to 2.0] | 0.3 [−2.0 to 2.5] | 0.82 |
| Mental‐health–related QOL | −0.8 [−2.5 to 1.0] | −0.3 [−2.2 to 1.6] | −0.4 [−3.0 to 2.1] | 0.73 |
| Depressive symptomology | −0.4 [−1.2 to 0.4] | 0.02 [−0.9 to 0.9] | −0.38 [−1.57 to 0.81] | 0.53 |
| ADL category | 0.1 [−0.1 to 0.4] | 0.2 [0.1–0.4] | −0.1 [−0.7 to 0.4] | 0.66 |
| Physician visits | −0.3 [−1.0 to 0.3] | −0.1 [−0.4 to 0.2] | −0.2 [−0.9 to 0.5] | 0.54 |
| Nights in hospital | 0.01 [−0.6 to 0.6] | −0.1 [−0.4 to 0.2] | 0.1 [−0.6 to 0.8] | 0.84 |
Intervention regression coefficient reflects mean difference between intervention and control conditions in level of change from T0 to T2. Models use regression with imputed values. Bonferroni adjustments for multiple comparisons mean the primary steps/day significance threshold is P<0.025 and the significance threshold for the remaining secondary and exploratory outcomes is P<0.0018. ADL indicates activities of daily living; BMI, body mass index; BP, blood pressure; CRP, C‐reactive protein; HbA1c, glycated hemoglobin; HDL, high‐density lipoprotein; QOL, quality of life.
Ordinal logistic regression.
Figure 2Outcomes with significant intervention effects at each time point, separated by intervention and control group. Bars represent 95% CIs. A, Mean steps per day. B, Stroke preparedness.